Author: George Underwood

China has denied Gilead a patent on its blockbuster hepatitis C drug Solvaldi, paving the way for cheap generic versions to appear in the country.

Shire has been named the most reputable pharma company in the US in a new report from the Reputation Institute

The UK Bioindustry Association (BIA) has responded to the government’s most recent review on antimicrobial resistance with its own suggestions for how to encourage new antibiotics.

Ireland’s Health Service Executive (HSE) has launched an eHealth Ireland website as a common platform for its plans to implement digital services across the country’s healthcare system. 

The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation in favour of rare disease drugs, according to a new study.